Global Cobamamide Drugs Market Growth 2023-2029

The report requires updating with new data and is sent in 48 hours after order is placed.

Cobamamide is mainly used for megaloblastic anemia, malnutrition anemia, pregnancy anemia, polyneuritis, radiculopathy, trigeminal neuralgia, sciatica, nerve palsy, it can also be used for nutritional disorders, radiation, and drug-induced leukopenia.

LPI (LP Information)' newest research report, the “Cobamamide Drugs Industry Forecast” looks at past sales and reviews total world Cobamamide Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Cobamamide Drugs sales for 2023 through 2029. With Cobamamide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cobamamide Drugs industry.

This Insight Report provides a comprehensive analysis of the global Cobamamide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cobamamide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cobamamide Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cobamamide Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cobamamide Drugs.

The global Cobamamide Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cobamamide Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cobamamide Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cobamamide Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cobamamide Drugs players cover Haerbin Medisan, North China Pharmaceutical Group, Chongqing Yaoyou Pharmaceutical, Sinopharm Group Rongsheng Pharmaceutical, Hainan Star Pharmaceutical, Hebei Zhitong Biopharmaceutical, Jiangsu Jiuxu Pharmaceutical and Jiuquan Dadeli pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cobamamide Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Injection
• Tablets

Segmentation by application

• Hospital
• Drug Store
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Haerbin Medisan
• North China Pharmaceutical Group
• Chongqing Yaoyou Pharmaceutical
• Sinopharm Group Rongsheng Pharmaceutical
• Hainan Star Pharmaceutical
• Hebei Zhitong Biopharmaceutical
• Jiangsu Jiuxu Pharmaceutical
• Jiuquan Dadeli pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cobamamide Drugs market?

What factors are driving Cobamamide Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cobamamide Drugs market opportunities vary by end market size?

How does Cobamamide Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

LIST OF TABLES

Table 1. Cobamamide Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Cobamamide Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Tablets
Table 5. Global Cobamamide Drugs Sales by Type (2018-2023) & (Kg)
Table 6. Global Cobamamide Drugs Sales Market Share by Type (2018-2023)
Table 7. Global Cobamamide Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global Cobamamide Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Cobamamide Drugs Sale Price by Type (2018-2023) & (US$/g)
Table 10. Global Cobamamide Drugs Sales by Application (2018-2023) & (Kg)
Table 11. Global Cobamamide Drugs Sales Market Share by Application (2018-2023)
Table 12. Global Cobamamide Drugs Revenue by Application (2018-2023)
Table 13. Global Cobamamide Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global Cobamamide Drugs Sale Price by Application (2018-2023) & (US$/g)
Table 15. Global Cobamamide Drugs Sales by Company (2018-2023) & (Kg)
Table 16. Global Cobamamide Drugs Sales Market Share by Company (2018-2023)
Table 17. Global Cobamamide Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Cobamamide Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global Cobamamide Drugs Sale Price by Company (2018-2023) & (US$/g)
Table 20. Key Manufacturers Cobamamide Drugs Producing Area Distribution and Sales Area
Table 21. Players Cobamamide Drugs Products Offered
Table 22. Cobamamide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cobamamide Drugs Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Cobamamide Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global Cobamamide Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Cobamamide Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Cobamamide Drugs Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Cobamamide Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global Cobamamide Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Cobamamide Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Cobamamide Drugs Sales by Country (2018-2023) & (Kg)
Table 34. Americas Cobamamide Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas Cobamamide Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Cobamamide Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas Cobamamide Drugs Sales by Type (2018-2023) & (Kg)
Table 38. Americas Cobamamide Drugs Sales by Application (2018-2023) & (Kg)
Table 39. APAC Cobamamide Drugs Sales by Region (2018-2023) & (Kg)
Table 40. APAC Cobamamide Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC Cobamamide Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Cobamamide Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC Cobamamide Drugs Sales by Type (2018-2023) & (Kg)
Table 44. APAC Cobamamide Drugs Sales by Application (2018-2023) & (Kg)
Table 45. Europe Cobamamide Drugs Sales by Country (2018-2023) & (Kg)
Table 46. Europe Cobamamide Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe Cobamamide Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Cobamamide Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe Cobamamide Drugs Sales by Type (2018-2023) & (Kg)
Table 50. Europe Cobamamide Drugs Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Cobamamide Drugs Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Cobamamide Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Cobamamide Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Cobamamide Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Cobamamide Drugs Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Cobamamide Drugs Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Cobamamide Drugs
Table 58. Key Market Challenges & Risks of Cobamamide Drugs
Table 59. Key Industry Trends of Cobamamide Drugs
Table 60. Cobamamide Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Cobamamide Drugs Distributors List
Table 63. Cobamamide Drugs Customer List
Table 64. Global Cobamamide Drugs Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Cobamamide Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Cobamamide Drugs Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Cobamamide Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Cobamamide Drugs Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Cobamamide Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Cobamamide Drugs Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Cobamamide Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Cobamamide Drugs Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Cobamamide Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Cobamamide Drugs Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Cobamamide Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Cobamamide Drugs Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Cobamamide Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Haerbin Medisan Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Haerbin Medisan Cobamamide Drugs Product Portfolios and Specifications
Table 80. Haerbin Medisan Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 81. Haerbin Medisan Main Business
Table 82. Haerbin Medisan Latest Developments
Table 83. North China Pharmaceutical Group Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. North China Pharmaceutical Group Cobamamide Drugs Product Portfolios and Specifications
Table 85. North China Pharmaceutical Group Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 86. North China Pharmaceutical Group Main Business
Table 87. North China Pharmaceutical Group Latest Developments
Table 88. Chongqing Yaoyou Pharmaceutical Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product Portfolios and Specifications
Table 90. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 91. Chongqing Yaoyou Pharmaceutical Main Business
Table 92. Chongqing Yaoyou Pharmaceutical Latest Developments
Table 93. Sinopharm Group Rongsheng Pharmaceutical Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product Portfolios and Specifications
Table 95. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 96. Sinopharm Group Rongsheng Pharmaceutical Main Business
Table 97. Sinopharm Group Rongsheng Pharmaceutical Latest Developments
Table 98. Hainan Star Pharmaceutical Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Hainan Star Pharmaceutical Cobamamide Drugs Product Portfolios and Specifications
Table 100. Hainan Star Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 101. Hainan Star Pharmaceutical Main Business
Table 102. Hainan Star Pharmaceutical Latest Developments
Table 103. Hebei Zhitong Biopharmaceutical Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product Portfolios and Specifications
Table 105. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 106. Hebei Zhitong Biopharmaceutical Main Business
Table 107. Hebei Zhitong Biopharmaceutical Latest Developments
Table 108. Jiangsu Jiuxu Pharmaceutical Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product Portfolios and Specifications
Table 110. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 111. Jiangsu Jiuxu Pharmaceutical Main Business
Table 112. Jiangsu Jiuxu Pharmaceutical Latest Developments
Table 113. Jiuquan Dadeli pharmaceutical Basic Information, Cobamamide Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product Portfolios and Specifications
Table 115. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 116. Jiuquan Dadeli pharmaceutical Main Business
Table 117. Jiuquan Dadeli pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Cobamamide Drugs
Figure 2. Cobamamide Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cobamamide Drugs Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Cobamamide Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Cobamamide Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Tablets
Figure 11. Global Cobamamide Drugs Sales Market Share by Type in 2022
Figure 12. Global Cobamamide Drugs Revenue Market Share by Type (2018-2023)
Figure 13. Cobamamide Drugs Consumed in Hospital
Figure 14. Global Cobamamide Drugs Market: Hospital (2018-2023) & (Kg)
Figure 15. Cobamamide Drugs Consumed in Drug Store
Figure 16. Global Cobamamide Drugs Market: Drug Store (2018-2023) & (Kg)
Figure 17. Cobamamide Drugs Consumed in Other
Figure 18. Global Cobamamide Drugs Market: Other (2018-2023) & (Kg)
Figure 19. Global Cobamamide Drugs Sales Market Share by Application (2022)
Figure 20. Global Cobamamide Drugs Revenue Market Share by Application in 2022
Figure 21. Cobamamide Drugs Sales Market by Company in 2022 (Kg)
Figure 22. Global Cobamamide Drugs Sales Market Share by Company in 2022
Figure 23. Cobamamide Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Cobamamide Drugs Revenue Market Share by Company in 2022
Figure 25. Global Cobamamide Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Cobamamide Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Cobamamide Drugs Sales 2018-2023 (Kg)
Figure 28. Americas Cobamamide Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC Cobamamide Drugs Sales 2018-2023 (Kg)
Figure 30. APAC Cobamamide Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe Cobamamide Drugs Sales 2018-2023 (Kg)
Figure 32. Europe Cobamamide Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Cobamamide Drugs Sales 2018-2023 (Kg)
Figure 34. Middle East & Africa Cobamamide Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas Cobamamide Drugs Sales Market Share by Country in 2022
Figure 36. Americas Cobamamide Drugs Revenue Market Share by Country in 2022
Figure 37. Americas Cobamamide Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas Cobamamide Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Cobamamide Drugs Sales Market Share by Region in 2022
Figure 44. APAC Cobamamide Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC Cobamamide Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC Cobamamide Drugs Sales Market Share by Application (2018-2023)
Figure 47. China Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Cobamamide Drugs Sales Market Share by Country in 2022
Figure 55. Europe Cobamamide Drugs Revenue Market Share by Country in 2022
Figure 56. Europe Cobamamide Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe Cobamamide Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Cobamamide Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Cobamamide Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Cobamamide Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Cobamamide Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Cobamamide Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Cobamamide Drugs in 2022
Figure 73. Manufacturing Process Analysis of Cobamamide Drugs
Figure 74. Industry Chain Structure of Cobamamide Drugs
Figure 75. Channels of Distribution
Figure 76. Global Cobamamide Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global Cobamamide Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Cobamamide Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Cobamamide Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Cobamamide Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Cobamamide Drugs Revenue Market Share Forecast by Application (2024-2029)